Randomized controlled trialHuman

Acute cardiovascular and hormonal effects of GH and hexarelin, a synthetic GH-releasing peptide, in humans

Journal of endocrinological investigation, 1999 Apr. Bisi G, Podio V, Valetto MR and 9 others.

Study type

Randomized controlled trial

Subjects

Human participants (PubMed MeSH: Humans)

Journal

Journal of endocrinological investigation

Published

1999 Apr

PubMed

PMID 10342360 ↗

DOI

10.1007/BF03343555 ↗

Where PepCue cites this

This paper is part of the evidence base behind this profile. Citing a study is not an endorsement of the compound: papers that found no effect are indexed the same way.

Hexarelin →

Indexed under

MeSH terms assigned by the National Library of Medicine.

AdultAldosteroneAngiocardiographyBlood PressureCardiovascular SystemEpinephrineFlushingHeart RateHemodynamicsHuman Growth HormoneHumansHydrocortisone

Other papers on Hexarelin

Clinical trial · 2001

Growth hormone-independent cardiotropic activities of growth hormone-releasing peptides in normal subjects, in patients with growth hormone deficiency, and in patients with idiopathic or ischemic dilated cardiomyopathy

Clinical trial · 1999

The effect of chronic hexarelin administration on the pituitary-adrenal axis and prolactin

Review · 2014

The cardiovascular action of hexarelin

PepCue indexes citation metadata only and does not reproduce abstracts or full text. Read the paper at the source links above. Nothing here is medical advice or a dose recommendation.

Educational and research reference only. Not medical advice, diagnosis, or dosing guidance. Flag an error on this page